{"query": "JM Financial retains Buy on Sun Pharma, lowers target price to Rs 2,025", "similar": [{"title": "Wipro turnaround work in progress; valuations leave little on the table: Analysts", "date": "2021-10-19 10:24:00.000", "impact": "-4.41%"}, {"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Hindalco shares down 4% today. JM Financial sees stock at Rs 530 level", "date": "2022-12-23 17:30:00.000", "impact": "+1.41%"}]}
{"query": "Sun Pharma shares fall over 4% today. Here’s what’s behind the drop", "similar": [{"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Sun Pharma shares reclaim four-digit mark after 7 long years", "date": "2022-10-27 16:31:14.000", "impact": "+0.41%"}, {"title": "Sun Pharma’s Market Cap Crosses Rs 2.5 Lakh Crore After Seven Years", "date": "2022-11-02 12:57:05.000", "impact": "+4.52%"}]}
{"query": "Sun Pharmaceutical Industries shares rise 1.79% in today's trading session", "similar": [{"title": "Sun Pharma’s Market Cap Crosses Rs 2.5 Lakh Crore After Seven Years", "date": "2022-11-02 12:57:05.000", "impact": "+4.52%"}, {"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Sun Pharmaceutical Industries (₹811.55): BUY", "date": "2021-09-30 06:10:00.000", "impact": "+7.15%"}]}
{"query": "Sun Pharma Q4 Results Preview: Sales Growth Led By gRevlimid, R&D Guidance For FY26 In Focus", "similar": [{"title": "Jefferies retains ‘buy’ call on Sun Pharma with 26% upside, stays bullish on Concert deal", "date": "2023-03-14 12:20:39.000", "impact": "+0.27%"}, {"title": "Sun Pharma CFO on what led to the growth in Indian and US businesses", "date": "2021-11-03 14:59:00.000", "impact": "-0.44%"}, {"title": "Sun Pharma: Ilumya Illuminates", "date": "2021-08-02 10:13:34.000", "impact": "+0.03%"}]}
{"query": "Sun Pharma Q4 Results: Profit declines 19% YoY; declares dividend of ₹5.50", "similar": [{"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Sun Pharma shares reclaim four-digit mark after 7 long years", "date": "2022-10-27 16:31:14.000", "impact": "+0.41%"}, {"title": "Sun Pharma’s Market Cap Crosses Rs 2.5 Lakh Crore After Seven Years", "date": "2022-11-02 12:57:05.000", "impact": "+4.52%"}]}
{"query": "Sun Pharma Share Price Falls Over 4% After Q4 Results | Revenue Rises 8%", "similar": [{"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Sun Pharma’s Market Cap Crosses Rs 2.5 Lakh Crore After Seven Years", "date": "2022-11-02 12:57:05.000", "impact": "+4.52%"}, {"title": "Sun Pharma shares reclaim four-digit mark after 7 long years", "date": "2022-10-27 16:31:14.000", "impact": "+0.41%"}]}
{"query": "Sun Pharmaceutical Industries sees surge in trading volume", "similar": [{"title": "Sun Pharmaceutical Industries (₹811.55): BUY", "date": "2021-09-30 06:10:00.000", "impact": "+7.15%"}, {"title": "Pharma sector to benefit from softening of raw material inflation: Cyndrella Carvalho", "date": "2023-04-20 12:36:00.000", "impact": "-1.00%"}, {"title": "Sun Pharma Wins U.S. FDA Approval For Anti-Fungal Injection — Analyst Take", "date": "2021-12-16 11:14:14.000", "impact": "+0.67%"}]}
{"query": "Sun Pharma Q4 Results: Cons PAT falls 19% YoY to Rs 2,154 crore; Rs 5.5/share dividend announced", "similar": [{"title": "Sun Pharma shares reclaim four-digit mark after 7 long years", "date": "2022-10-27 16:31:14.000", "impact": "+0.41%"}, {"title": "Why Sun Pharma is among the top losers today?", "date": "2022-05-31 08:50:00.000", "impact": "-4.41%"}, {"title": "Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo", "date": "2022-03-21 22:54:00.000", "impact": "-1.11%"}]}
